이뮤니크 R&D

학술활동

1) 학술대회 발표

대한면역학회 학술대회 포스터발표 (인천, 2022)
– Regulatory T cell from umbilical cord blood as novel source of cell therapy
– In vitro expanded umbilical cord blood-derived regulatory T cells as an emerging cell therapy for preventing graft versus host disease in a humanized mouse model

EBMT(European Blood and Marrow Transplantation) 2023 학술대회 구연발표 (49th Annual Meeting of the EBMT, Paris, France 4/23 – 4/26/2023)
– Large numbers of highly potent cord blood-derived regulatory t cells could be acquired by using culture platform of cord blood-derived mesenchymal stem cells

2) 초청강연

2023, The 10th China Cord Blood Symposium, Guangzhou, China
– Adoptive cellular immunotherapy for cord blood transplantation – Superior potential of regulatory T cells derived from cord blood

2022, The 10th Summit of Cord Blood and Transplantation, Hefei, China
– Adoptive cellular immunotherapy for cord blood stem cell transplantation

2021, The 9th Summit of Cord Blood and Transplantation, Hefei, China
– The role of regulatory T cells in GVHD and pre-engraftment syndrome after stem cell transplantation

2021, Guangdong CB Symposium, Gunagzhou, China
– Evolution of cord blood-based cell therapy

2021, The 9th China Cord Blood Symposium, Chengdu, China
– Immune cell therapy using cord blood

면역세포치료제

이뮤니크 연구소에서 개발중인 면역세포치료제에 대한 정보를 확인하실 수 있습니다.

면역세포치료제

이뮤니크 연구소에서 개발중인 면역세포치료제에 대한 정보를 확인하실 수 있습니다.

메뉴